avenuetx.com (ATXI) Stock Quotes

ATXI (Avenue Therapeutics Inc) - company brandmark

This daily price chart for Avenue Therapeutics (ATXI) on the GURU.Markets platform reflects the asset's dynamics, with a value of 0.43. Avenue Therapeutics (ATXI) is actively developing its portfolio of treatments for rare pathologies and pain syndromes. Clinical trials of the oral drug AJ201 and patent activity are driving the increase in quotes. Furthermore, the business is implementing safe intravenous opioid analogs, creating socially significant solutions for postoperative recovery.

Avenue Therapeutics Inc - ATXI Share Price (period 07/04/2022 - 03/29/2025)

Avenue Therapeutics, Inc (ATXI) - metric breakdowns and financial figures

Analysis of all company metrics:avenuetx.com ATXI
Signature product of Avenue Therapeutics Inc.

High expenditures by Avenue Therapeutics (ATXI) on late-stage trials of neurological drugs create a situation of deferred operating leverage, where business value depends on future approvals. Analyzing the asset's price trend on GURU.Markets, an investor sees a market valuation of expected revenues, where every movement on the chart reflects a reassessment of the company's capitalization through the prism of the market's willingness to pay for potential commercial success.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|OVID - Price Chart|Price Performance Chart ABOS (Acumen Pharmaceuticals)|CRVO: Stock Price|ATHE: Price|CLNN (clene.com) - Stock Price|pepgen.com (PEPG) - Market Chart|Price Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Price Performance Chart|Stock Price ANVS (Annovis Bio Inc)|gracetx.com (GRCE) - Market Price|AIFF - Price Chart|anewmeds.com (KLTO) - Stock Quotes|NeuroSense Therapeutics, Ltd. (NRSN) - Price Chart|Market Price Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Price Chart MetaVia|Share Price NRXS (NeurAxis Inc.)|Stock Price HSDT|PASG: Quote Chart|Neuphoria Therapeutics, Inc. - Stock Quotes|NERV: Share Price|athira.com - Stock Price|ADXN - Stock Price|ALZN: Stock Price|CYCN - Market Chart|PTIX (Protagenic Therapeutics, Inc.) - Stock Price|pasitheaclinics.com (KTTA) - Market Chart|Price Chart Cortigent Inc (CRGT)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel